Please try another search
The fund will primarily invest, via the EQT SGH Wholesale Emerging Companies fund, in companies that have a market capitalisation of less than $500m at the time of first purchase and cash.
Name | Title | Since | Until |
---|---|---|---|
Rory Hunter | - | 2019 | Now |
Biography | Rory joined SGH as part of the merger with DMP Asset Management in 2019. Prior to joining DMP in October 2016, Rory spent three years at Arjent Investment Management, a London based Investment Manager. Rory is Portfolio Manager of the SGH Medical Technology Fund and the SGH Opportunities Fund. Rory has a Bachelor of Commerce with a double-major in Finance and Economics from the University of Melbourne. | ||
Adrian Di Mattina | - | 2001 | Now |
Biography | Adrian joined SGH in 2001 as one of the founding principals. He is a Director and Portfolio Manager of the SGH Emerging Companies Fund. Adrian has 30 years’ experience in the investment industry, primarily gained at SGH and NAM – where he was a Senior Portfolio Manager of Small Companies and also spent over 10 years in Australian Equities and Fixed Interest at NAM. Prior to this, Adrian worked at the Bank of America, in the Fixed Interest and Money Market departments. Qualifications: MBA, B.Com, F Fin |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review